Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma
ClinicalTrials.gov study NCT02166463. IPD Sharing: Not stated. Countries: 3. Publications: 9.
Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00807495. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of MK-3475 Alone or in Combination With Copanlisib in Relapsed or Refractory NK and T-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02535247. IPD Sharing: Not stated. Countries: 1. Publications: 1.
S0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00109928. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Participants With Refractory Aggressive Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02348216. IPD Sharing: YES. Countries: 6. Publications: 11.
Proton Therapy for Hodgkin Lymphoma
ClinicalTrials.gov study NCT00850200. IPD Sharing: Not stated. Countries: 1. Publications: 23.
Brentuximab Vedotin and Bendamustine for the Treatment of Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (ALCL)
ClinicalTrials.gov study NCT01657331. IPD Sharing: NO. Countries: 2. Publications: 1.
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemot
ClinicalTrials.gov study NCT01461928. IPD Sharing: Not stated. Countries: 24. Publications: 3.
A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02703272. IPD Sharing: Not stated. Countries: 20. Publications: 2.
Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediat
ClinicalTrials.gov study NCT03526250. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)
ClinicalTrials.gov study NCT00156013. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT02581631. IPD Sharing: Not stated. Countries: 6. Publications: 2.
Ofatumumab and Bendamustine Followed by Maintenance Ofatumumab for Rituximab Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (B-NHL)
ClinicalTrials.gov study NCT01294579. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma
ClinicalTrials.gov study NCT01534078. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL)
ClinicalTrials.gov study NCT01716806. IPD Sharing: Not stated. Countries: 2. Publications: 4.
Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01535924. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study for Patients With Non-Hodgkin's Lymphomas
ClinicalTrials.gov study NCT00542919. IPD Sharing: YES. Countries: 5. Publications: 1.
Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00720876. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)
ClinicalTrials.gov study NCT00096460. IPD Sharing: YES. Countries: 1. Publications: 1.
Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00460109. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.